GenScript Biotech and T-MAXIMUM Biotech Forge cGMP sgRNA Alliance

GenScript Biotech, the world's leading life-science research tools and services provider, and T-MAXIMUM Biotech, a biotechnology company pioneering univers...

August 10, 2023 | Thursday | News
Agilent Launches its First Integrated Biology Center at Monash University in Malaysia

Agilent Technologies Inc. (NYSE: A)  announced the opening of a new full-scale Integrated Biology Center located at Monash University in Malaysia...

August 08, 2023 | Tuesday | News
Astellas Invests in Poseida Therapeutics to Redefine Cancer Cell Therapy

Poseida is a clinical-stage biotechnology company dedicated to advancing a new class of cancer cell therapy and gene therapy products using genetic enginee...

August 08, 2023 | Tuesday | News
Piramal Pharma Reports Strong Start to Financial Year with Revenue Surge and Promising Growth Prospects Across Business Segments, Says Chairperson Nandini Piramal

Nandini Piramal, Chairperson, Piramal Pharma Limited said, "We had a positive start to the new financial year with healthy revenue growth and improvem...

August 04, 2023 | Friday | News
Molecular Targeting Technologies and Singapore's Theranostics Center Gain HSA Approval for EBTATE® Trial in Nasopharyngeal Cancer

Somatostatin receptor 2 (SSTR2) is found in 81% of primary, recurrent, and metastatic NPC patients. EBTATE, the first patented and only long-acting peptide...

August 03, 2023 | Thursday | News
Collaboration Shines as BIO Asia–Taiwan 2023 Concludes

Event co-organizer the Taiwan Bio Industry Organization (Taiwan BIO), stated that international participation was notably higher this year due to the lifti...

August 02, 2023 | Wednesday | News
Australia: First Patient Dosed in Chemotherapy-Free Soft Tissue Sarcoma Trial.

Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immu...

July 31, 2023 | Monday | News
South Korea's PharmAbcine Initiates Phase I Trial of Novel TIE2 Antibody in nAMD"

The study, consisting of single ascending-dose cohort and multiple ascending-dose cohort, has dosed the first of 36 planned study subjects. The Phase I cli...

July 27, 2023 | Thursday | News
Samsung Biologics releases 2023 ESG Report, reaffirming its commitment to net-zero progress and corporate social responsibility

“Samsung Biologics is fully committed to engaging in sustainable business practices for the positive impact it has on our clients, society, and the w...

July 18, 2023 | Tuesday | News
Japan's ThinkCyte & FIMM Forge Research Partnership to Fight Blood Cancer

"Blood cancers are a complex, heterogeneous set of diseases and while the treatment landscape has advanced in recent years, there is still a lot we don't k...

July 18, 2023 | Tuesday | News
Examining the Biopharma Industry's Declining Resilience: Factors, Vulnerabilities, and Strategies for Growth

Join us for an in-depth conversation with Chua Keng Hock as we explore the challenges, strategies, and future prospects of the biopharma industry in today'...

July 18, 2023 | Tuesday | Interaction
Avantor® Inaugurates Expanded Singapore Hub

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies, a...

July 13, 2023 | Thursday | News
HUTCHMED Begins Phase I Study of Novel SHP2 Inhibitor for Advanced Solid Tumors in China

The clinical trial is a multi-center, open-label study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy profile of HMPL-415 ...

July 10, 2023 | Monday | News
INOVIQ and Promega announce global marketing agreement for EXO-NET exosome solutions

INOVIQ and Promega sign a global joint marketing agreement for INOVIQ’s EXO-NET® exosome capture technology and Promega Nucleic Acid purificati...

July 07, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close